Articles about Biotech – Page 3 of 8

Seattle biotech Silverback Therapeutics raises $85M, just six months after raising $78.5M

Seattle biotech startup Silverback Therapeutics continues to raise capital to support development of its therapies for cancer, fibrosis, and other conditions.… Read More

Athira Pharma prices IPO at $17/share, will raise $204M in third Washington state IPO of 2020

Athira Pharma will raise at least $204 million as the Seattle biotech startup becomes a public company on Friday. Athira… Read More

Bill Gates and Jeff Bezos-backed cancer detection company Grail, led by ex-Juno CEO, files for IPO

Cancer detection startup Grail today filed to go public as the Silicon Valley biotech aims to raise more funding for… Read More

Seattle’s Athira Pharma files for IPO to fund quest for Alzheimer’s and Parkinson’s breakthroughs

Athira Pharma is aiming to go public. The Seattle biotech filed initial IPO paperwork Wednesday, a surprising move that would… Read More

Researcher with Seattle ties awarded $4.2M to develop DNA vaccine against COVID-19

A researcher with ties to Seattle-based biotech company OncoSenX has received a $4.2 million grant from the Canadian Institutes of… Read More

Chinook Therapeutics to merge with Aduro Biotech as it pushes forward with kidney disease therapies

Chinook Therapeutics, a biotech company creating targeted therapies for kidney diseases, has agreed to merge with Berkeley, Calif.-based Aduro Biotech.… Read More

Seattle biotech startup Athira raises $85M to develop therapies for Alzheimer’s and Parkinson’s

The foundation of Athira Pharma began while Leen Kawas was earning her Ph.D. in molecular pharmacology at Washington State University nearly… Read More

A-Alpha Bio wins $620,000 grant to work on ‘molecular glue’ for treating disease

A-Alpha Bio, a Seattle venture that began at the University of Washington, has won a $620,472 grant from the National… Read More

Good Therapeutics raises $11M to develop ‘context dependent’ protein drugs

Seattle biotech startup Good Therapeutics raised another $11 million to create “context dependent” protein drugs that act only when needed.… Read More

Seattle biotech startup OncoSenX raising more cash for cancer-fighting therapies

Biotech startup OncoSenX is raising more cash to help support its pipeline of therapeutics that aim to kill cancer cells… Read More

Microsoft and Adaptive Biotechnologies partner to study immune response to COVID-19

Microsoft and Seattle-based Adaptive Biotechnologies announced Friday they will work together to map the immune response to COVID-19. The goal… Read More

Seattle biotech startup Silverback Therapeutics raises $78.5M

Seattle biotech startup Silverback Therapeutics raised a $78.5 million investment round to support development of its therapies for cancer, fibrosis,… Read More

Seattle Genetics stock jumps 17% on breast cancer drug trial success

Shares of cancer drug maker Seattle Genetics soared more than 17 percent Monday morning following positive results for a new… Read More

Shares of Gates-backed Vir Bio tumble after $143M IPO to fund infectious disease efforts

It was a rough Wall Street debut for Vir Biotechnology, a San Francisco company with ambitious plans to battle infectious… Read More

Biotech experts gather at the White House for ‘Summit on America’s Bioeconomy’

More than 100 biotech researchers, industry executives and government officials met at the White House today for a summit focusing… Read More

Stem cell startup Silene Biotech acquired by NanoSurface Biomedical in all-Seattle deal

NanoSurface Biomedical has snapped up Silene Biotech in a union of two Seattle startups that bets on the growing importance… Read More

Alexandria doubles down on decades-long Seattle biotech bet with Mercer ‘Mega Block’ deal

As it closes in on one of the most valuable land deals in Seattle history, Alexandria Real Estate Equities is… Read More

Gov. Inslee helps Bluebird Bio open new ‘nest’ for cancer research efforts in Seattle

Bluebird Bio is growing its nest in Seattle. The leading biotech company held a ribbon-cutting event Friday to celebrate the… Read More

‘Mega Block’ in Amazon’s backyard will become a life sciences campus following $143.5M deal; proceeds to fund affordable housing

One of the last big chunks of land in the booming Seattle neighborhood of South Lake Union will turn into… Read More

Biotech

Seattle biotech Silverback Therapeutics raises $85M, just six months after raising $78.5M

Athira Pharma prices IPO at $17/share, will raise $204M in third Washington state IPO of 2020

Bill Gates and Jeff Bezos-backed cancer detection company Grail, led by ex-Juno CEO, files for IPO

Seattle’s Athira Pharma files for IPO to fund quest for Alzheimer’s and Parkinson’s breakthroughs

Researcher with Seattle ties awarded $4.2M to develop DNA vaccine against COVID-19

Chinook Therapeutics to merge with Aduro Biotech as it pushes forward with kidney disease therapies

Seattle biotech startup Athira raises $85M to develop therapies for Alzheimer’s and Parkinson’s

A-Alpha Bio wins $620,000 grant to work on ‘molecular glue’ for treating disease

Good Therapeutics raises $11M to develop ‘context dependent’ protein drugs

Seattle biotech startup OncoSenX raising more cash for cancer-fighting therapies

Microsoft and Adaptive Biotechnologies partner to study immune response to COVID-19

Seattle biotech startup Silverback Therapeutics raises $78.5M

Seattle Genetics stock jumps 17% on breast cancer drug trial success

Shares of Gates-backed Vir Bio tumble after $143M IPO to fund infectious disease efforts

Biotech experts gather at the White House for ‘Summit on America’s Bioeconomy’

Stem cell startup Silene Biotech acquired by NanoSurface Biomedical in all-Seattle deal

Alexandria doubles down on decades-long Seattle biotech bet with Mercer ‘Mega Block’ deal

Gov. Inslee helps Bluebird Bio open new ‘nest’ for cancer research efforts in Seattle

‘Mega Block’ in Amazon’s backyard will become a life sciences campus following $143.5M deal; proceeds to fund affordable housing

Seattle biotech startup OncoSenX raises $3M to develop tumor-killing therapeutics

Isilon co-founder Sujal Patel building mysterious biotech startup, backed by Andreessen Horowitz

Bristol-Myers Squibb exec on how can Seattle grow — and keep — big biotech companies

Historic steam plant in Seattle gets a fresh new look courtesy of Fred Hutch

Just Biotherapeutics, backed by Gates Foundation, snapped up by German biotech firm for up to $90M

Seattle startup Blaze Bioscience makes brain tumors ‘light up like a Christmas tree’ in first trial

How scorpion venom helps improve brain cancer surgery in children by making tumors glow

Seattle biotech startup Good Therapeutics raises $11M to make smart cancer therapies

Digital health investments hit an all-time high of $8.6B in 2018

New Seattle startup emerges from UW to develop cancer-fighting protein three decades in the making

Adaptive Biotechnologies signs blockbuster deal with Genentech for personalized cancer treatments worth up to $2 billion